RAND outlines the potential impacts of a drop in demand for Afghan opiates, urging the international community to monitor the market and invest in rural development.

Kavanagh et al. provide evidence on the negative impact of criminalising key populations on HIV status awareness and viral suppression.

PRI and IDPC detail how policymakers and practitioners in the criminal legal system can reduce the imprisonment of women for drug-related offences in line with international standards.

Christopher Hallam (GDPO) argues for increased support toward heroin-assisted treatment (HAT) by national governments and international bodies, including the INCB.

SSDP considers that the 'drugs cost lives' narrative, although well-meaning, is stigmatising and harmful, and fuels damaging approaches based on prohibition, punishment and criminalisation.

Iversen and Maher suggest low adherence to antiretroviral therapy could be greatly reduced by engagement with opioid agonist therapy.

Rêgo et al. argue that, despite the positive progress enabled by the Portuguese model, its limited ambitions, lack of update, and regressions toward punitive responses have severely undermined its potential.

EMCDDA explores the epidemiology of drug-related health problems in prisons, discussing available harm reduction measures and persistent challenges in these settings.

PITCH recaps their successes from the past five years in advancing health and human rights issues for those affected by HIV.

Kvamme et al. suggest that a significant proportion of Danish users of cannabis as medicine are motivated by a desire to alleviate their ailments whilst minimising the negative side effects that they associate with legal prescription drugs.

Grisaffi et al. argue that the successes of coca regulation in Bolivia could be replicated in Peru, as long as efforts centre community empowerment and participation.

HRI outlines harm reduction practices and interventions aimed at improving the health and well-being of people who engage in chemsex.

UNODC summarises the state of drug markets and provides insight into a range of related health challenges, including in relation to COVID-19.

The 64th session of the CND was marked by the increase in prominence of health and human rights narratives, the proceedings' 'hybrid format' and a welcome long-overdue shift in the US stance on harm reduction.

HRI reports on the impact of the involvement of criminal legal systems, policing and the military in the COVID-19 response.

Dame Carol Black analyses trends and impact of thriving informal drug markets in England, and provides recommendations on how to address health-related challenges.

IDPC and HRI document disruptions and challenges, as well as positive developments faced by harm reduction in relation to the COVID-19 pandemic.

A manual from Community Harm Reduction on how organisations can improve their health initiatives with MSM, particularly in Asian countries.

UNHCHR exposes a culture of systemic racism within law enforcement against people of African descent.

HIV Legal Network addresses the importance of human rights standards in the response to public health crises.